Thymoquinone decreases F-actin polymerization and the proliferation of human multiple myeloma cells by suppressing STAT3 phosphorylation and Bcl2/Bcl-<sub>XL </sub>expression
<p>Abstract</p> <p>Background</p> <p>Thymoquinone (TQ), the major active component of the medicinal herb Nigella sativa Linn., has been described as a chemopreventive and chemotherapeutic compound.</p> <p>Methods</p> <p>In this study, we investig...
Main Authors: | Badr Gamal, Mohany Mohamed, Abu-Tarboush Faisal |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://www.lipidworld.com/content/10/1/236 |
Similar Items
-
The Effects of Thymoquinone on Viability, and Anti-apoptotic Factors (BCL-XL, BCL-2, MCL-1) in Prostate Cancer (PC3) Cells: An In Vitro and Computer-Simulated Environment Study
by: Javad Saffari_Chaleshtori, et al.
Published: (2019-08-01) -
Dinaciclib synergizes with BH3 mimetics targeting BCL‐2 and BCL‐XL in multiple myeloma cell lines partially dependent on MCL‐1 and in plasma cells from patients
by: Manuel Beltrán‐Visiedo, et al.
Published: (2023-12-01) -
Ameliorative Effect of Thymoquinone and Thymoquinone Nanoparticles against Diazinon-Induced Hepatic Injury in Rats: A Possible Protection Mechanism
by: Walaa M. Nassar, et al.
Published: (2023-09-01) -
Thymoquinone Prevents Myocardial and Perivascular Fibrosis Induced by Chronic Lipopolysaccharide Exposure in Male Rats - Thymoquinone and Cardiac Fibrosis -
by: Fereshteh Asgharzadeh, et al.
Published: (2018-12-01) -
Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies
by: Katrine Melvold, et al.
Published: (2022-03-01)